TPWA
TEVA icon

Twin Peaks Wealth Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-230
Closed -$6.93K – 1989
2026
Q1 		$6.93K Buy
+230
New +$7.4K ﹤0.01% 1250
2025
Q3 		– Sell
-24
Closed -$398 – 1915
2025
Q2 		$398 Buy
+24
New +$387 ﹤0.01% 1951

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Twin Peaks Wealth Advisors's TEVA Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026, closing a stake of 230 shares — an estimated $6.93K sold.

Twin Peaks Wealth Advisors first reported a position in TEVA in Q2 2025 and held it in 2 quarters. The position peaked at $6.93K in Q1 2026. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 230 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $6.93K.
  • Twin Peaks Wealth Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2025 and held it in 2 quarters.
  • Twin Peaks Wealth Advisors's Teva Pharmaceutical Industries Limited position peaked at $6.93K in Q1 2026.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.